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ABSTRACT
EROL AGI: Effects of local administration of ketorolac tromethamine, a nonsteroidal anti-
inflammatory drug, on orthodontic tooth movement in rats.
(Under the direction of Dr. William R. Proffit)
Tooth movement rates can be inhibited by prostaglandin inhibitors acting 
systemically. We investigated the locally delivered effects of ketorolac tromethamine (KT), a 
potent nonsteroidal anti-inflammatory drug (NSAID), on orthodontic tooth movements in 
twelve Wistar rats. U-shaped expansion springs were positioned between upper first molars 
exerting equal and reciprocal, laterally directed forces for seventeen days. Every fourth day 
1.5 mg of KT in solution was delivered around one molar and saline solution was injected 
adjacent to the contralateral molar. Subsequent to a wash-out period lasting fifteen days of 
continued expansion, the appliances were removed, the teeth allowed to relapse for thirteen
days while the same schedule was maintained for the NSAID delivery.  Combining the data 
from all the teeth that received KT and comparing those with the control data, no significant 
differences were seen with their movements during the expansion or relapse phases.
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I. INTRODUCTION
A biologic principle in orthodontic tooth movement is that prolonged mechanical 
pressure on teeth results in remodeling of periodontal structures, which includes the 
periodontal ligament (PDL) and alveolar bone (Proffit, 2000).  A condition for the 
remodeling activities, and ultimately tooth displacement, is the occurrence of an 
inflammatory response (Vandevska-Radunovic, 1999).  During orthodontic treatment, low-
intensity and continuous forces are placed on teeth, causing physical distortion beyond the 
bio-adaptability or bio-elasticity of the PDL fibers (Storey, 1973). The pressure and tension 
within the PDL, causing a shift in tooth position, promotes, within a few hours, a cascade of 
events leading to an inflammatory response (Davidovitch et al., 1988).  T he change in the 
perfusion dynamics in the PDL is followed by the cellular production and release of 
inflammatory mediators within the periodontium, that ultimately allows bone remodeling and 
tooth translation (Proffit, 2000). 
Acute inflammation is characterized by redness, heat, swelling, pain and loss of 
function.  These macroscopic changes are produced by a progression of vascular events, such 
as vasodilation and increased permeability of small blood vessels within a damaged area, the 
exudation of fluids, and leukocyte migration into the extravascular spaces.  These vascular 
changes are accompanied by the release of inflammatory mediators, namely histamine, 
prostaglandins, leukotrienes and cytokines (Stephenson, 1992). 
2The cardinal signs of inflammation are often observed during orthodontic treatment, 
such as redness and swelling of the gingiva (Vandevska-Radunovic, 1999).  Pain that begins 
within several hours after application of orthodontic forces and may last for a few days is a 
common experience in nearly all orthodontic patients.  As pain leads to impaired function, 
biting and chewing become more uncomfortable, which leads to some degree of functional 
loss (Scheurer et al., 1996).
For more direct evidence of inflammatory alterations in the PDL during orthodontic 
treatment, studies were conducted on animal subjects (reviewed in Vandevska-Radunovic, 
1999).  Changes in the vasculature of the periodontium were observed in monkeys and dogs 
during orthodontic tooth movements.  Within minutes of force application, teeth moved
within the PDL space compressing towards the alveolar wall.  In the compressed or pressure 
area, PDL space was narrowed and blood vessels were partially or completely occluded.  On 
the tension side, PDL space was widened and blood vessels were dilated and engorged with 
blood (Khouw and Goldhaber, 1970).  After three days of continuous force applied to the 
teeth, the tension side showed osteoblasts lining the bone, while the pressure side still had no 
evidence of bone resorption (Khouw and Goldhaber, 1970). Bone deposition and resorption 
started around the seventh day of applied forces. Ligaments on the tension side remained 
stretched and clear evidence of new bone formation was observed.  The pressure side had an 
increase in vascularity with many new capillary loops in close proximity to the osteoclast 
lined alveolar bone undergoing active resorption (Khouw and Goldhaber, 1970).
Other studies provided evidence that changes in the vascularization within the PDL 
were directly correlated to the start of the inflammatory process.  Vandevska-Radunovic et 
al., (1994) reported that vasodilation occurred within minutes on the tension side of the PDL 
3with increased blood flow and fluid exudates from dilated blood vessels.  Furthermore, an 
immediate extra-vascular movement of leukocytes into the tissue spaces was observed on the 
pressure side, which was characterized by a decrease in PDL space and partially occluded 
blood vessels (Iida et al., 1996).  Within days of sustained pressure, several lines of 
inflammatory cells, such as monocytes and polymorphonuclear leukocytes, known to 
differentiate into macrophages and osteoclasts, were observed throughout the periodontium 
(Iida et al., 1992).
For teeth to move through bone, both soft and hard tissues must be remodeled.
Breakdown of bone by osteoclasts occurs in the compression side, the area toward which the 
tooth is moving.  On the other hand, osteoblasts deposit newly formed bone in the tension 
side, the area away from which the tooth is moving, while the fibroblasts contribute to the 
turnover of the collagen matrix of the PDL (Proffit, 2000). Studies by Kvam (1972), Smith 
and Roberts (1980), McCulloch and Melcher (1983) and McCulloch et al., (1987 ) showed 
orthodontic forces promoted the mitotic activity of resident fibroblasts, osteoclasts and
osteoblasts.  Since the entire vascular network was increased, it facilitated the migration of 
precursor cells from the immediate marrow spaces towards the active remodeling sites.
These changes in the cellular activities and the consequent inflammatory process were found 
to be controlled and sustained by various inflammatory mediators detected within the 
periodontium (Vandevska-Radunovic, 1999).  During acute episodes of inflammation, there 
were increased levels of prostaglandins (PGs), cyclic adenosine monophosphate (cAMP), 
interleukin-1 (IL-1), and tumor necrosis factor (TNF) (reviewed in Yamaguchi and Kasai, 
2005).
4IL-1 and TNF are pro-inflammatory cytokines known to promote acute and chronic 
inflammation, possibly by inducing the expression of specific pro-inflammatory proteins, 
such as the monocyte chemoattractant protein-1 from fibroblasts (Dinarello, 1991; Ozaki et 
al., 1996). Both IL-1 and TNF levels increased in the PDL and alveolar bone in cats during 
orthodontic tooth movement, suggesting they play a role in bone remodeling events 
(Davidovitch et al., 1988 ; Davidovitch, 1991; Saito et al., 1991).  In accord with these data, 
other investigators observed a synergistic increase in the levels of IL-1 and PGE2 in the 
gingival crevicular fluid (GCF), following sustained mechanical stress (Grieve et al., 1994;
Lee et al., 2004)., again suggesting these molecules may play a role in bone remodeling 
events.
Prostaglandins (PGs), metabolites of arachidonic acid metabolism, are local hormone-
like agents produced by many cells, including osteoblasts, within seconds of cell injury.  In 
response to mechanical or chemical stimuli, arachidonic acid is produced from the plasma 
membrane phospholipids and can be converted to PGs by a family of cyclooxygenase 
enzymes (COXs) (Offenbacher et al., 1981).  Among the members of the COX family, both 
the constitutive enzyme COX-1 and the inducible form COX-2, responsive to cytokines, 
bacterial lipopolysaccharides and growth factors, contribute to increase the PGE2 levels 
(Murakami and Kudo, 2004; Gordon et al., 2002; Yamaguchi and Kasai, 2005).
Among the PGs produced, PGE2 is known to increase vascular permeability and 
chemotactic properties of the white blood cells.  PGE2, which is produced in the bone mainly 
by osteoblasts, stimulates both bone formation and resorption and has been implicated in the 
pathogenesis of certain conditions such as periodontitis and osteomyelitis, which are 
associated with bacterial induced bone loss.  Furthermore, PGE2 was shown to facilitate the 
5increased formation of osteoclasts, thereby escalating bone and root resorption (Yamaguchi 
and Kasai, 2005; Boekenoogen et al., 1996).  Further implicating PGE2 as an important 
mediator of bone resorption, increased levels in the periodontal tissues, as measured in the 
GCF, were found to correlate with periodontal bone resorption and the progression of 
periodontal disease (Offenbacher et al., 1981).
In orthodontic treatment the rate of bone resorption and formation are factors in 
determining the velocity of tooth movement.  This knowledge led investigators to study 
whether PG levels could be altered to influence the pace of tooth movement.  In fact, PGs 
were successfully used to increase the speed of tooth movement.  Injections of exogenous 
PGE1 and PGE2 adjacent to investigative teeth increased their tempo of up to two times as 
compared to the control teeth in rats, monkeys and humans (Kale et al., 2004; Leiker et al., 
1995; Yamasaki, et al., 1982, 1984).  However, a significant amount of root resorption was 
observed over a 2-week period in rats that received local injections of exogenous PGE2 
(Boekenoogen et al., 1996).  PGE2 was also found in periodontal cysts, dentigerous cysts, 
keratocysts and ameloblastomas, lesions that are associated with bone and root resorption 
(Harris et al., 1973).  Injections of exogenous PGs may increase rates of tooth movement, but 
they also have the potential to introduce extremely negative inflammatory reactions if given 
the chance.
On the other hand, the inhibition of tooth movement by using PG inhibitors could be 
advantageous in many clinical orthodontic situations by increasing the anchorage value of 
teeth.  Anchorage in orthodontics is defined as the resistance to unwanted tooth movement.  
Teeth that can maintain their position in a dental arch by their increased resistance to 
movement can help absorb the reactive force of moving other teeth (Proffit, 2000).  
6Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to be non-specific COX 
inhibitors.  They act as anti-inflammatory drugs by both inhibiting the COX enzymes 
expression and their catalytic activities, thus decreasing the overall PG production
(Murakami and Kudo, 2004).  Yamasaki et al., (1980) showed that indomethacin, a NSAID, 
inhibited the number of osteoclasts around teeth that received the drug injection.  More 
recently, indomethacin was shown to decrease the rate of bone turnover in miniature pigs
(Giunta et al., 1995) and total tooth movement in rats and cats (Mohammed et al., 1989; 
Chumbley and Tuncay, 1986).
In other studies, flurbiprofen, a different NSAID compound, decreased the number of
osteoclasts but did not affect tooth movement rates (Sandy and Harris, 1984).  Similarly, 
Wong et al., (1992) showed that aspirin, an irreversible COX inhibitor (Sari et al., 2004), did 
not decrease the rate of tooth movement in guinea pigs.
Hoping to clarify the literature disagreement on whether an anti-inflammatory drug 
could decrease inflammation resulting from orthodontic pressure and thereby increase the 
anchorage value of teeth, we hypothesized that the effects of another NSAID , ketorolac 
tromethamine (KT), could alter tooth movement when administered locally.  KT was chosen 
because it was found to decrease concentrations of PGE2 in dogs (Pasloske et al., 1998) and 
to be a potent bone resorption inhibitor in humans (Allison et al., 1993).  Due to its strong
anti-inflammatory effect, its water solubility, lack of irritation to mucosal tissue and its 
absence of taste, topical forms of KT have been used successfully to halt the progression of 
periodontal disease (Kelm et al., 1996).
7To test the hypothesis that KT could be used locally to inhibit tooth movement and 
increase the anchorage value of teeth, we set up a two-phase experiment with Wistar rats.
Using a split-mouth design, the experimental plan was to create transverse expansion of the 
upper first molars while teeth were exposed to KT on one side and saline solution on the 
other.  Impressions to show the position of the teeth were taken during the expansion phase 
of tooth movement, and again as relapse tooth movement occurred after the expansion was 
completed.  The impressions were examined and recorded with a scanning electron 
microscope. Images were then digitized, so that a special software program, developed at the 
National Institutes of Health (NIH), could be used to calculate the relative movements of 
teeth.
II. MATERIALS AND METHODS 
A. ANIMALS
Rats were chosen for this project because they have been used in many similar 
orthodontic tooth movement studies (Yamasaki et al., 1980; Yamasaki, 1983; Mohammed et 
al., 1989; Vandevska-Radunovic et al., 1994; Leiker et al., 1995; Boekenoogen et al., 1996; 
Soma et al., 1999; Kyrkanides et al., 2000; Kalia et al., 2004; Dolce et al., 2003).  T heir 
dentition may be small but nonetheless large enough to allow the necessary study.  Rats have 
been identified as a good animal model because of their skeletal adaptation to mechanical 
forces (Jee et al., 1991; Ren, et al., 2004).  Additionally, rats were easily obtainable, 
relatively inexpensive to house and feed and more could be worked on simultaneously than 
larger animals.  Although the size of the animals made it difficult, the NSAID was injected 
adjacent to the teeth under investigation, preventing the drug from falling out of the sulcus as 
could have occurred with larger sized animals with larger gingival sulci.
The University of North Carolina at Chapel Hill’s (UNCCH) Institutional Animal 
Care and Use Committee (IACUC) pre-application tests were successfully taken by all the 
participants of this project who were involved with direct animal contact.  The application to 
conduct this investigation was approved by IACUC in Dec 2004 and again in Oct 2005 as per 
annual requirements.  The application protocol number assigned was 04-278.0-A.
A total of 16 male Wistar rats at 6-7 weeks of age were purchased from Harlan 
Laboratory (Indianapolis, Indiana), provided a standard dry laboratory food, Purina RMH 
93000, and allowed to drink water ad libitum.  They were housed two per cage in a 
temperature- and climate-controlled room.  Only male rats were ordered to eliminate the 
hormonal changes associated with estrus.  These rats were exposed to automated cycles of 
twelve hours of light and twelve hours of darkness.  The average weight was 260.5 grams (g)
per rat on day 1 at the beginning of the experiment .  The rats were randomly housed two per 
cage and the cages were labeled A through H.  Within each cage, one rat chosen at random 
had its tail tattooed while the other did not.  This allowed distinguishing between rats in each 
cage. The tattooed rat was identified as rat number one and the non-tattooed rat was labeled 
as number two for that particular cage.  Therefore, the rats were labeled and named A1, A2, 
B1, B2, C1, C2, D1, D2, E1, E2, F1, F2, G1, G2, H1, H2.
B. DRUG
The NSAID used in this study was ketorolac tromethamine (KT) because it was 
found as a more potent inhibitor of bone resorption than other NSAIDs, such as flurbiprofen, 
naproxen, piroxicam or ibuprofen (Allison et al., 1993).  In a study by Kelm et al., (1996), 
KT was used locally as the active ingredient in a mouth rinse and dentifrice.  Their results 
showed the concentration of KT in the GCF was at high enough levels to inhibit PGE2
production.  In a similar study, Jeffcoat et al., (1995) managed to halt the progression of 
periodontal bone loss using KT oral rinses better than tablets of flurbiprofen taken perorally.
KT is considered a potent NSAID and is normally prescribed for moderately severe 
acute pain that would otherwise require analgesia at the opioid level.  It is available 
commercially in solution form as Toradol® IV/IM (Roche Laboratories, Basel, Switzerland).  
It is packaged in carpules and TORADOL® is available for intravenous or intramuscular (IM) 
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administration as 15 mg in 1 ml (1.5%) and 30 mg in 1 ml (3%) in sterile solution.  The 
carpule with 60 mg in 2 ml (3%) of KT in sterile solution is available for IM administration 
only. The solutions contain 0.1% citric acid, 10% weight by volume (w/v) alcohol and
sodium chloride in sterile water. The pH is adjusted with sodium hydroxide or hydrochloric 
acid, and the solutions are packaged with nitrogen. The sterile solutions are clear and slightly 
yellow in color.  The solution used for this experiment was the IM form (Fig. 1).
Fig. 1: Ketorolac tromethamine carpule.
Ketorolac tromethamine is a member of the pyrrolo-pyrrole group of the nonsteroidal 
anti-inflammatory drugs and its chemical name is (± )-5-benzoyl-2,3-dihydro-1H-
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pyrrolizine-1-carboxylic acid, compounded with 2-amino-2-(hydroxymethyl)-1,3-
propanediol (1:1).  The chemical structure is shown in Fig. 2.
Fig. 2:  Chemical structure of ketorolac tromethamine.
The investigative teeth in this study had 1.5 mg subperiosteal KT injections of the 
commercially available Toradol® IM solution at a concentration of 60 mg/2 ml (3% w/v) .  
The control teeth received subperiosteal injections of 0.05 ml of 0.9% sterile saline solution 
(150 mM NaCl).
The anesthetic used in this study was the injectable form of a ketamine solution.  The 
solutions and concentrations used were: Ketamine 70 mg/kg, Xylazine 4 mg/kg and 0.9% 
saline solution (150 mM NaCl).  This anesthetic solution was administered by intraperitoneal
(IP) injections.  Within several minutes the rats were immobilized and anesthetized.  The 
effects of the anesthetic normally lasted between 45 and 60 minutes per rat.  After the 
required work on the rats was completed during each session, the rats were placed into the 
recovery position (Fig. 3).  Once awake and alert, they were then placed back into their 
cages.
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Fig. 3: Two rats in the recovery position after anesthesia.
During the pilot study, isoflurane inhalation was evaluated as the anesthetizing agent.  
Isoflurane was an effective anesthetic, however the management and manipulation of the rats 
while simultaneously managing the nasal canula was deemed impossible when working 
alone.  Therefore, the inhalation technique was abandoned and the injectable form of the 
ketamine solution was used throughout the study.
C. ORTHODONTIC APPLIANCE
A pilot study using four Wistar rats was conducted in preparation for this project.  In 
an attempt to replicate the appliance design and protocols as described by Igarashi et al.,
13
(1994), we fabricated and successfully placed 0.012” nickel titanium (NiTi) orthodontic 
springs intraorally in these rats.  However, we found these springs were not retained in their 
mouths between operative sessions.  We were not able to reproduce the same retention as 
Igarashi et al., (1994) .
Springs of the same design were made using 0.010” stainless s teel (SS) wires.  Their 
improved contour and fit helped increase the retention of the appliances.  The 0.010” SS 
springs were retained in the mouths of the rats at each of the pilot sessions and these findings 
lead us to use the stainless steel springs during the actual experiment.  None of the tooth 
movement data from the pilot study was evaluated.
The springs were shaped into a U pattern with small projections at the ends to allow 
for improved retention interproximally between the upper first and second molars (Fig. 4).
These U-shaped standard sized expansion springs were placed into each rat’s mouth between 
the upper right (UR) and left (UL) first molars and held in the mouth by their own expansion 
force, which moved the UR and UL first molars laterally (Fig. 5).  The dimensions were as 
follows: length: 5.0 mm, width: 5.5 mm and the two small projections were 1.5 mm.
The forces produced by the springs used in this study were remarkably different.  
Highest force levels were produced by the 0.012” SS springs per unit of activation.  At a 
deflection of 1.5 mm, the 0.012” SS spring produced 59.3 g of force while the 0.012” NiTi 
spring elicited 10.3 g of force.  The force -deflection curves for the three springs are 
represented in Fig. 6. The forces were measured using a hand-held force gauge, the 
Orthometer by OrthoMeasurements, a Division of Young Research & Development, Inc., 
(Avon, CT).
14
Fig. 4: Schematic of the orthodontic appliance.
5.5 mm
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Fig. 5:  0.012” NiTi orthodontic spring in position between upper first molars of the rat 
maxilla.
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Fig. 6:  Force-deflection curves for the three springs used.
D. EXPERIMENTAL PROCEDURES
1. KT Application
In each animal, 1.5 mg KT in the standardized commercially available solution was 
injected locally adjacent to either the UR or UL first molar. This study was performed as a 
split mouth design, therefore the contralateral first molar, the control tooth had 0.05 ml of 0.9 
% saline solution (150 mM NaCl) administered in the same manner.  The syringes used for 
local administration of either KT or saline were 30 gauge 0.5 inch needles (Becton, 
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Dickinson and Company, Franklin Lakes, NJ).  By convention, the rats tagged with a tattoo 
on their tails and named number one of the cages they lived in, always had their upper right 
first molars as the site  for the KT injections.  Their UL first molars were their control teeth.  
The rats in all the cages that were labeled number two by their lack of having a tattoo always 
had their upper left first molars as the sight for the KT injections.  Their UR first molars were 
their control teeth.
2. Frequency of KT Injections
General anesthesia was induced by a ketamine solution.  Then every four days, under 
anesthesia, KT and saline were administered to the predetermined UR and UL first molars.  
This schedule was undertaken to prevent excess animal stress, tissue damage and animal 
demise by either the anesthetic or the NSAID.
3. The Expansion - Wash-out - Relapse Phases
These twelve rats underwent two phases of experiments.  Sandwiched between these 
two phases was a period of wash-out lasting two weeks.  During this wash-out time the 
expansive appliances remained in the mouths of the rats but no injections or impressions
were made.
The first part of this project was the expansion phase.  General anesthesia and 
administration of KT and saline were conducted every fourth day for seventeen days.  This 
allowed for five sessions of general anesthesia, five maxillary impressions (day 1, 5, 9, 13 
and 17) and four local injections of KT and saline (day 1, 5, 9 and 13) per rat.  On day one a 
maxillary impression was taken, an orthodontic spring was positioned in each rat’s mouth 
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and 1.5 mg of KT in solution was administered (Fig. 7).  Then every four days, the rats were 
put under general anesthesia and the ketorolac tromethamine was administered adjacent to 
either the UR or UL first molars.  On day 17, the rats were put under general anesthesia, 
impressions taken and the appliances were left in their mouths without any further injection 
of KT or saline for a period of two weeks.
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Fig. 7: Rat’s mouth before (A) and after (B) orthodontic spring appliance was positioned 
between the upper first molars.
B
A
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Work was not done on the rats during this two week wash-out period.  Only the 
appliances were left in their mouths to allow for continued buccal movement of the first 
molars.  This was done to allow for a more predictable period of relapse tooth movement.
The second part of this experiment, the relapse phase, started at the end of the two 
week non-intervention, wash-out phase.  The relapse period lasted 13 days, allowed for four 
sessions of general anesthesia, four maxillary impressions (days 1, 5, 9, 13) and three 
injections of KT and saline (days 1, 5 and 9) per rat. On day one of this phase, the springs 
were removed (Fig. 8), impressions taken and KT administered around the same teeth as 
previously done.
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Fig. 8: Day 1 of the relapse phase of the experiment, after the orthodontic appliance was 
removed from the rat’s mouth.
The surgical set-up and procedures were conducted on a Styrofoam pad (Fig. 9).  
Paper clips, rubber bands, thumb tacks and tape were used to place the rats in the prone 
position and to help keep their mouths open (Fig. 10).  Surgical loops and lights were used 
often and were available at all times.
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Fig. 9: Styrofoam pad, paper clips, rubber bands and tape used in the surgical set-up.
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Fig. 10: Position of the rat during the intraoral operative work.
4. Impressions
Wax impressions of the maxillary arch were taken at each time point after the rats 
were anesthetized and the NSAID and saline were injected.  These maxillary impressions 
were taken using a customized impression tray with red rope wax as the impression material.  
The impression trays were customized with a handle that allowed an intraoral approach 
without interference from the upper incisors.  Pink Triad® Transheet Visible Light Cure Tray 
Material, (Dentsply International Inc., York, PA) was used as the base and handle for the 
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trays.  Strips of the soft tray material were cut into pieces measuring 8 mm by 20 mm on a 
hard acrylic lab cutting board (Fig. 11).  
Fig. 11: Rectangular pieces used to make the impression tray bases.
These rectangular pieces of Triad® were light cured in the Dentsply Trubyte Triad®
2000TM (Dentsply International Inc., York, PA) for 4-5 minutes.  Once cured , the pre-cut 
rectangular pieces of the Triad tray material were trimmed at one end to produce a 45 degree 
angle to the bottom of the base (Fig. 12). 
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Fig. 12: Preparation of the 45 degree angle in the tray base.
Fig. 13:  Completed impression tray base.
The base (Fig. 13) was then completed.  To fabricate the handles of the trays, another 
sheet of the pink Triad® material was cut into the same dimensions as previously described.  
Before curing these rectangular pieces, they were first peeled away from the cutting board, 
hand shaped to resemble an “L”.  These L shaped rectangular pieces were then adapted to the 
previously cured flat rectangular tray bases, to be cured and used as handles (Fig. 14). 
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Fig. 14: Preparation of the L shaped handles of the customized impression trays.
For the impression, a strip of red rope wax (Heraeus Kulzer Inc., Armonk, NY) was 
folded on itself to make it twice as wide.  This strip was then cut into pieces that were 
approximately one cm long (Fig. 15).  These rectangular cubes of wax were then adapted to 
the 45 degree angled base ends and shaped into a flat angulated plane also at the 45 degree 
incline (Fig. 16). 
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Fig.  15: Rectangular wax cubes ready to be melted onto the custom made impression trays.
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Fig. 16:  Wax being adapted onto the impression tray base (A) and completed 
impression tray (B).
The bottoms of the trays were left flat which allowed them to be secured properly 
onto the stage of the scanning electron microscope.  An example of an impression is depicted 
in Fig. 17.
A
B
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Fig. 17: Example of a rat’s maxillary arch impression taken with the custom 
impression tray.
5. Scanning Electron Microscope Imaging
To archive these impressions, to locate precise reference points and make 
measurements, these trays went through a standardized protocol prior to scanning them using
the scanning electron microscope (SEM).  First the trays were covered with a thin conductive 
film (150 Angstroms) of gold/palladium using a Polaron 5200 sputter coater.  These trays
were then processed for the SEM by drying the samples in air, mounting them onto specimen 
stubs with double sided carbon adhesive tabs and colloidal silver paint.  The gold/palladium 
covered trays were then very carefully placed into the JEOL 6300 scanning electron 
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microscope (Jeol of America Peabody, MA) operating at 10kV.  Digital images were 
collected at 10 x magnification and saved onto a Zip Disc® (Iomega, San Diego, CA). From 
the Zip Disc® the images were then copied to a SanDisk® 1GB Memory Stick (Sunnyvale, 
CA).  The images were then transferred to an IBM T40 ThinkPad laptop computer (Armonk,
New York).
6. Measurement Technique
Tooth movements in each rat were evaluated by measuring the distances the first 
molars moved relative to a fixed point centered between the upper third molars.  To 
accomplish this, an identifiable point was located on either first molar at each time point for 
each rat.  Another identifiable point was then located on either third molar at each time point.  
These four points from each impression were overlapped at the center of the line connecting 
the third molar spots, the reference point (RP).  Superimposing the four dots of successive 
images at the RP allowed the change in position of the first molars at each time point to be 
measured.
An imaging software program, Image J, (National Institutes of Health, Bethesda, 
MD) was used in this project for making measurements.  It is considered a part of the public 
domain and is readily available via the Internet (http://rsb.info.nih.gov/ij/).  It was used to 
identify the four position points in each successive image of each rat.  The calibrated 
coordinate system offered in Image J was also utilized.  The (X, Y) coordinates for each of 
these 4 points, were used to translate, rotate and superimpose the images at the RP.
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Fig. 18:  Successive scanning electron microscope images of rat E1. The images were lined 
up adjacent to one another and Image J program was used to locate and match the identical 4 
points in each image.
Each rat had a series of impressions taken during the expansive and relapse phases of 
the study.  These impressions, after being scanned and saved to a laptop computer, were 
opened using Image J software.  All the successive images were aligned one next to another
(Fig. 18).  Since each tooth, in each rat, had unique and distinct marks, identifying the same 
points in each successive impression was possible. We were able therefore to identify and 
label the same four points in each image. The four points were then numbered 
conventionally to represent the following.  Point 1 (Pt. 1) was always the left posterior 
identifying point on the upper left (UL) third molar.  Pt. 2 was always located on the UL first 
molar.  Pt. 3 was always located on the UR first molar and Pt. 4 was always the right 
posterior identifying point on the third molar.  The center of the line connecting points 1 and 
4 (Line 1-4) was the RP where the impression images were superimposed (Fig. 19). 
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Fig. 19:  Scanning electron microscope image of a wax impression. Pts. 1, 2, 3, 4 and RP are 
indicated by white arrows.  Pt. 1 is located on the UL third molar, Pt. 2 is located on the UL 
first molar, Pt. 3 is located on the UR first molar, and Pt. 4 is located on the UR third molar.  
Reference point (RP) is the center of Line 1-4.  10x magnification.
Image J, its (X- Y) coordinate system and mathematical formulas were used to overlap 
the points 1 through 4 at the RP.  Each set of four points was imagined as being on a two 
dimensional plane.  The planes were then rotated and translated using rotational and 
translational calculations so that the lines connecting the points 1 and 4 of each image 
overlapped the original image’s Line 1-4.  The planes were rotated and translated not only to 
Pt. 1
Pt. 2Pt. 3
Pt. 4
RP
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overlap one another along Line 1-4, but more precisely, at the midpoints of the lines 
connecting pts. 1 and 4.  Microsoft Excel (Redmond, WA) was used to calculate the 
rotational and translational figures.  Once the images were superimposed at the RP, the 
distances that the first molars moved relative to where they were at day one, were calculated 
using the Pythagorean theorem, a2 + b2 = c2 where a was the distance moved in the X or 
horizontal axis, b was the distance moved in the Y or vertical axis and c was the total 
distance the first molars moved since day 1.
7. Statistical Analysis
The distances measured and reported in the results section are the means, unless 
otherwise stated, of all the data gathered from all the rats through each phase of the 
experiment, excluding data from the pilot study.  Statistical analyses were conducted using 
the exact Wilcoxon matched pairs signed rank test, to determine the statistical differences 
between the measured upper first molar movements for each time point.  Differences 
between movements of the NSAID and saline injected molars were considered significant at 
p<0.05.
III. RESULTS
A. CONSIDERATIONS OF METHODOLOGY
All the rats in this study had normal and consistent weight gain (Appendix A), except 
two (H1, H2) that lost weight between the wash-out period and the sixth day of the relapse 
phase due to a malfunction of the water feeding line.  Once this problem was corrected, both 
rats regained normal weight.
There were no appreciable systemic side-effects in any of the rats, such as loss of
appetite or change in body weight, and there were no other signs of inflammation such as 
swelling, redness or bleeding.  However, on the fifth day of the relapse phase, rats E1, G1, 
H1, H2 and on the ninth day of the relapse phase, rats C1, D2 had denuded palates adjacent 
to the upper first molars where KT was administered.  The underlying bone and portion of 
the palatal root surface of the upper first molars were visible.  Tissue injury was not seen at 
the site of the saline injections.
During the study, 0.010” SS appliances were retained less predictably than in the pilot 
study.  Three animals had their intraoral expansion springs stay in throughout the 
experimental period exerting the directional forces desired, but in the remaining nine, the 
appliances were not always retained in the mouths.  In those cases, the springs made of 
0.010” SS were replaced with 0.012” SS springs with the same design.  Although retention 
improved with the newer wires, these springs were not always retained in the rat mouths.
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B. EXPANSION PHASE
Three out of twelve rats (C1, C2, G2) retained the initial springs at the site of 
placement throughout the period of investigation.  Two rats (D1, E2) did not retain their 
springs during any of the operative sessions.  Three rats (F2, H1, H2) had their springs 
missing on one of the four days of data collection.  One rat (F1) had its appliance missing on 
two of the four days of data collection and three rats (D2, E1, G1) had their springs missing 
on three of the data collection days (Table 1).
Four rats (D1, E2, F1, F2) did not have their intraoral springs at the beginning of the 
relapse phase.  Therefore, on day one of what would have been the relapse phase, another 
expansion spring was positioned transpalatally from upper first molar to upper first molar 
and the animals went through a second stage of expansion.  Three of these four rats (D1, E2, 
F1) retained their springs at each operative session thereafter while one rat (F2) had the 
appliance missing at one session.  This second set of expansion data for rats D1, E2, F1 and 
F2 is included in the expansion phase table (Table 1)
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Site where 
Ketorolac 
Tromethamine 
Delivered: Day 
1
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
C1 UR First Molar Yes +8.5 Yes +8.2 Yes -15.9 Yes:Day 16 +55.6
C2 UL First Molar Yes -6.2 Yes -8.8 Yes +6.5 Yes: Day 16 -45.6
D1 UR First Molar No: Day 7 No: Day 11 No: Day 15 No: Day 18
D2 UL First Molar No: Day 7 No: Day 11 No: Day 15 Yes: Day 18 -4.4
E1 UR First Molar No No Yes: Day 14 -1.6 Could not anesthetize
E2 UL First Molar No Could not anesthetize No No
F1 UR First Molar No Yes -30.5 Yes: Day 14 +20.9 No
F2 UL First Molar Yes -28.0 Yes +7.4 No Yes: Day 18 -15.6
G1 UR First Molar No No No Yes +23.7
G2 UL First Molar Yes -42.3 Yes +6.4 Yes +21.9 Yes +12.7
H1 UR First Molar No Yes +30.6 Yes +14.9 Yes +67.0
H2 UL First Molar No Yes -13.1 Yes -25.9 Yes +27.1
D1* UR First Molar Yes +64.8 Yes +47.3 Yes -13
E2* UL First Molar Yes -47.9 Yes -32.1 Yes +19.4
F1* UR First Molar Yes -46.2 Yes -43.2 Yes -67.5
F2* UL First Molar No Yes -21.9 Yes -45.3
EXPANSION PHASE
Day 5 Day 9
R
A
T
S
Day 13 Day 17
Table 1:  Appliance retention and relative tooth movement during the expansion phase.  The percentage difference in movements of 
the KT treated teeth was calculated relative to the saline treated teeth. *Rats D1, E2, F1, F2 went through a second expansion phase.
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KT treated first molars versus saline treated first molars. The calculated distances 
the upper first molars moved, regardless which side received KT or saline injections, was 
nearly the same at each time point during the expansion phase.  Movement data from each 
time point of the expansion phase was combined and it revealed that on day 5, the KT treated 
upper first molars moved 362 µm while the saline treated upper first molars moved 428 µm.  
On day 9, the KT treated upper first molars moved 444 µm while the control upper first 
molars moved 465 µm.  On day 13, the KT treated upper first molars moved 511 µm and the 
control upper first molars moved 549 µm.  On day 17, the KT treated upper first molars 
moved 724 µm and the control upper first molars moved 682 µm.  Figure 20 graphically 
displays the mean ± SD distances moved by the KT and saline treated upper first molars at 
each time point.  Differences in movements between the KT treated and saline treated teeth 
were statistically insignificant at each time point. The individual data of each rat during the 
expansion phase are reported in the appendices.
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Figure 20:  Time-course movements of KT and saline treated first molars during the 
expansion phase. Each column represents the mean distance (µm) ± SD.  The sample sizes 
were: n=7 on day 5, n=11 on day 9, n=11 on day 13, n=8 on day 17.
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C. RELAPSE PHASE
Eight rats (C1, C2, D2, E1, G1, G2, H1, H2) went through the relapse phase of this 
study (Table 2).  On day one, the expansion springs that were retained during the two week 
wash-out period were removed.  Four rats (G1, G2, H1, H2) had their impressions taken on 
day one of the relapse phase just before the springs were removed, and four rats (C1, C2, D2, 
E1) had their impressions taken just after the springs were removed.  Four of the animals 
(C1, E1, G1, H1) had the KT delivered locally adjacent to the UR first molars and the other 
four rats (C2, D2, G2, H2) had it delivered around the UL first molars.  Six of the eight rats 
(C1, C2, D2, E1, G1, G2) had KT injected and impressions taken on days 1, 5, 9 and 13.  
Two of the rats (H1, H2) had KT injected and impressions taken on days 1, 6, 10 and 13.
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Site where 
Ketorolac 
Tromethamine 
Delivered: Day 
1
Appliance in Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Appliance in
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
C1 UR First Molar Yes +1.3 +311.1 +339.2
C2 UL First Molar Yes -56.5 -73.1 -10.3
D1** UR First Molar No New Appliance
D2 UL First Molar Yes -93.9 -5.4 +143.3
E1 UR First Molar Yes +20.7 -9.1 +7.1
E2** UL First Molar No New Appliance
F1** UR First Molar No New Appliance
F2** UL First Molar No New Appliance
G1 UR First Molar Yes +35.5 +192.1 -1.1
G2 UL First Molar Yes -63.7 +106.2 -2.8
H1 UR First Molar Yes Day 6 +4.2 Day 10 same +39.4
H2 UL First Molar Yes Day 6 +203.4 Day 10 +43.1 Day 14 +8.1
RELAPSE PHASE
R
A
T
S
Day 1 Day 5 Day 9 Day 13
Table 2: Appliance retention and relative tooth movement during the relapse phase. The percentage difference in movements of the 
KT treated teeth was calculated relative to the saline treated teeth. ** Rats D1, E2, F1 and F2 did not have relapse data because on day 
one of what should have been the relapse phase, their springs were missing.   They underwent a second expansion phase and their data 
are listed with the expansion phase data.
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KT treated first molars versus saline treated first molars. The calculated distances 
the upper first molars moved, regardless which side received KT or saline injections, was 
nearly the same at each time point during the relapse phase.  Movement data from each time 
point during the relapse phase were combined and it revealed that on day 5, KT treated upper 
first molars moved 147 µm and the saline treated upper first molars moved 170 µm.  On day 
9, KT treated upper first molars moved 239 µm while the saline treated upper first molars 
moved 183 µm.  On day 13, the KT treated upper first molars moved 222 µm and the control 
upper first molars moved 177 µm.  Figure 21 graphically displays the mean ± SD distances 
moved by the KT and saline treated upper first molars at each time point  The differences in 
the calculated movements were not statistically significant.  The individual data of each rat 
during the relapse phase are reported in the appendices.
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Figure 21: Time-course movements of KT and saline treated first molars during the relapse 
phase. Each column represents the mean distance (µm) ± SD. The sample sizes were: n=8 on 
day 5, n=8 on day 9 and n=8 on day 13.
IV. DISCUSSION
It is well documented that teeth translate through bone by means of a remodeling 
process promoted by the inflammatory response (Proffit, 2000).  Inflammation results from a 
cascade of biological events and PGs have been identified as key mediators for osteoclastic 
activity leading to bone resorption (Klein and Raisz, 1970).  Investigators used these findings
to effect tooth movement rates by altering PGE2 levels in their experimental subjects.  
Yamasaki et al., (1982, 1984) injected exogenous PGE1 and PGE2 locally in monkeys and 
humans and increased the rates of tooth movement.  Chumbley and Tuncay, (1986) and Zhou 
et al., (1997) used systemically administered PGE2 inhibitors to decrease the overall tooth 
movement rates in cats and rats.
In our study, we attempted to effect tooth movement rates by delivering a potent anti-
inflammatory drug adjacent to teeth hoping to increase their anchorage value.  Our 
hypothesis was that, by delivering a NSAID locally, the PGE2 production at that site would 
diminish.  This would decrease the bone resorption rate at the site, which in turn would cause 
a decrease in tooth movement.  The results from our investigation revealed that the 
movements of the upper first molars, during the expansion and relapse phases, were similar 
regardless if they received ketorolac tromethamine or saline.  The differences in tooth 
movements were not statistically significant.  To help explain these results, the methods used 
in this study may need to be examined in detail. 
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A. CONSIDERATIONS OF METHODOLOGY
1. ANIMAL
The rat model has been used in past toxicological and orthodontic tooth movement 
studies (Yamasaki et al., 1982,1984; Mohammed et al., 1989, Vandevska -Radunovic et al., 
1994; Leiker et al., 1995; Boekenoogen et al., 1996; Soma et al., 1999; Kyrkanides et al., 
2000; Kalia et al., 2003; Dolce et al., 2003).  Jee et al., (1991), and Ren, et al., (2004), report 
that the rat animal model is suitable for such investigations because of their skeletal 
adaptation to mechanical forces.  Although the rat oral cavity and dentition were small, it was 
relatively easy to insert a fixed orthodontic appliance and take intraoral maxillary 
impressions.  However, we encountered some technical difficulties in administering 
submucosal injections into the rat palate around the investigative teeth.  Due to the thin and 
fibrous rat palatal tissues, occasionally we observed some leakage during the placement of 
the saline or KT solutions, suggesting that the desired KT concentration may not have been 
consistently achieved in all the experimental periods.  We also noted mucosal stripping of 
palatal tissues in several rats at the site of KT injections during the relapse phase.  The 
volume of the drug or the concentration administered beneath the thin palatal mucosa could 
have contributed to this effect, masking the anti-inflammatory action of the drug.
2. PHARMACEUTICAL AGENT
Our choice to test ketorolac tromethamine as our investigative NSAID was dictated 
by three reasons; its anti-inflammatory potency (Allison et al., 1993), effectiveness in its 
topical application in inhibiting PGE2 production (Kelm et al., 1996) and its tissue tolerance 
upon local injection (Chellman et al., 1994).  Kelm et al., (1996) showed that KT 
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significantly reduced PGE2 levels in the GCF when it was locally administered, two times 
daily, for eight days in humans.  They also showed that the half life of KT within the GCF 
was 30 minutes.  The schedule used during our study for delivering KT was once every four 
days.  It is possible the frequency of the drug delivery was not often enough to clinically 
inhibit tooth movement.
KT was found to be well tolerated when it was injected into the paws and muscles of 
rats (Chellman et al., 1994) and non-irritating when applied to human mucosal tissues (Kelm 
et al., 1996; Jeffcoat et al., 1995).  However the KT solution used in our study also contained
ethanol, 10% w/v.  A severe synovial inflammation was found in rat knees after five days 
following a single KT injection to that site, but not in the control knees injected with a saline 
solution (Irwin et al., 1998).  The authors investigated whether the ethanol could have been 
responsible for the inflammation, but they found the application of 10% w/v ethanol by itself 
did not elicit any inflammatory response in the rat synovial tissue.  Based on these 
observations, even though the anatomical and histological characteristics of the rat synovia 
may not be exactly comparable to those of the palatal mucosa, we could speculate that the 
inflammatory reaction could have been caused by the three-week long exposure to localized 
KT.  However, we could not exclude ethanol either directly causing or contributing to the 
necrosis observed in some of the rat palatal tissues.  Injections of a 10% w/v ethanol solution 
would help clarify this point.  At this point, it is unclear whether the drug concentration, 
volume, alcohol content or the method of application contributed to the stripping of the 
palatal tissues.
It has been reported that indomethacin not only inhibits PG synthesis but is also a 
potent inhibitor of cAMP-dependent protein kinase (Kantor and Hampton, 1978). These 
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protein kinases may in turn have a significant influence on the activity of osteoclasts. Thus 
indomethacin may have affected tooth movement in previous studies not only by inhibiting 
PG production, but probably by interfering with other biologic processes too. KT is a potent 
PG inhibitor however it is known that PGs are not the only mediators of bone resorption 
associated with tooth movement.  A more ideal NSAID could be used in future studies.
3. ORTHODONTIC APPLIANCE
In the design of our experimental protocol and orthodontic appliance, we tried to 
replicate the work of Igarashi et al., (1994).  In their studies, they placed intraoral springs 
made of 0.012” NiTi wire and were able to demonstrate good retention of the springs.  
However, our attempts to achieve consistent retention of that type of appliance in the rat 
mouths were not successful.  In our hands, the 0.012” NiTi wires that we initially used in the 
pilot study were not retained by the rats.  To improve the retention of the springs, the 
composition and stiffness of the wires were changed to 0.010” SS, maintaining the appliance 
design.  However, their retention remained inconsistent during the actual study.  The springs 
were retained in the rat mouths more predictably as we further increased the stiffness of the 
wires, passing to a 0.012” SS wire.  These springs increased the force levels applied to the 
rats’ teeth from 10.3 g produced by the NiTi springs to 59.3 g, at a deflection of 1.5 mm.  It is 
possible this large increase in applied force levels may have exceeded the pharmaceutical 
effect or capability of the locally delivered KT.  Wong, et al., ( 1992) suggested that forces of 
25 g or more might stimulate maximal bone resorption and tooth movement overwhelming 
any inhibitory effects of an anti-inflammatory drug in the guinea pig.  Since rats have similar 
to smaller sized teeth, the forces used in our study may have been too high, overpowering the 
anti-inflammatory effects of KT.
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4. MEASUREMENT TECHNIQUE
Our measurement technique involved the identification of four arbitrary points, each 
one located on a different tooth.  Of the four points identified from each impression, the two 
localized on the third molars, were chosen as fiduciary points and they were used to help 
superimpose the images for calculating differential tooth movements of both upper first 
molars.  Ideally, fiduciary points should be completely stationary at all times to allow 
absolute measurements.  Due to the growth of the young rats, whose weights were almost 
doubled by the end of the experiment, from the consecutive sets of images, we observed that, 
in addition to the first molars, the two fiduciary points on the third molars also moved, even 
though slightly, during the expansion and relapse phases. Therefore, the tooth movements 
were measured from a single reference point that was the midpoint of the line that connected 
the two fiduciary points.  Since these two fiduciary points moved throughout the study, the 
point where all the images were superimposed, the RP was not truly fixed.  Therefore the 
measurements of the differential first molar movements may not be accurate.
B. INTERPRETATION OF RESULTS
Pharmaceutical manipulation of the inflammatory response during orthodontics to 
increase and decrease tooth movement rates has been demonstrated.  Systemically 
administered PG inhibitors can cause tooth movement rates to decrease.  Indomethacin and 
ibuprofen, two different PG inhibitors, were used by Zhou et al., (1997), Kehoe et al.,
(1996), Mohammed et al., (1989), Chumbley and Tuncay (1986) to decrease tooth movement 
in their animal models.  A bisphosphonate drug, another type of osteoclast-mediated bone 
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resorption inhibitor, normally prescribed to counter osteoporosis, proved to decrease tooth 
movement rates in rats when systemically and locally administered (Igarashi et al., 1994). 
Our hypothesis of applying NSAIDs locally to take advantage of their anti-
inflammatory effects, at the scene of application, to increase the anchorage value of specific 
teeth, remains a theory since this study did not prove our hypothesis to be true.  However, by 
modifying some of the methods used, it is possible that favorable outcomes may be achieved.
C. FUTURE WORK
During this study, injection of the KT solution under the thin palatal tissues posed 
several problems that should be addressed in the future by changing the drug delivery 
methodology.  The use of subcutaneous, surgically positioned, sustained-release 
microspheres, from which a pharmacological agent can be delivered at sufficient levels 
throughout the study period, is an option that might be considered (Sinha et al., 2005; Dolce 
et al., 2003). Alternatively, it is possible to implant osmotic pumps in the subcutus of the 
dorsocervical region of rats to release an NSAID near a specific target (Soma et al., 1999). 
The continuous infusion of KT to localized sites would eliminate three problems encountered 
in our study: 1) the need for periodical, high volume injections of the NSAID, 2) the problem 
of leakage from the injection sites and 3) the possible presence of toxic drug solvents such as 
ethanol.  The time sustained drug delivery by microspheres could allow the investigator to 
reduce the amount of drug used and still observe inhibition in tooth movement.  In fact, a 
lower, but constant, local concentration of the KT, that would otherwise require more 
frequent injections, would address the issue of the short half-life of KT within the GCF.  
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Furthermore, this experimental approach might diminish the local side-effects that could 
have been caused by the high volume or higher concentration of KT at the site of injection.
Future work will also benefit from a redesign of our intraoral appliance. Even though 
the appliance that we used in our study had the advantages of being simple and easy to 
position in the rat’s mouth, it was often ineffective due to its poor retention. Using a 
cemented or permanently bonded spring would eliminate a few uncontrollable factors, such 
as the rat’s innate desire and ability to remove an intraoral appliance.  In a revised protocol, 
an appliance that is secured in the rat’s mouth could be made of 0.012” NiTi wire.  This type 
of wire, unlike the SS wire of the same diameter, has the intrinsic property of yielding low 
forces with large deflections.  In our experimental conditions, the NiTi spring exerted forces 
that were within a physiological range (Ren et al., 2004) and more likely to be within the 
effective pharmaceutical range of KT.
Additionally, in our preliminary study, we attempted to measure the PG levels in the 
GCF, but we were unable to fit the detection paper strip inside the rat gingival crevice.  
However, we do believe the measurements of PGs in the GCF and the histological 
examination of the KT treated maxilla and its soft tissues would be very useful.  Histological
examinations may help determine the lowest effective KT concentration levels that give the 
greatest benefit of decreased inflammatory mediators.  This approach would also help 
elucidate whether chronic exposure to KT could cause undesired side effects, such as 
necrosis and denuding of palatal tissues.
Lastly, a fixed fiduciary point, one that does not move is important when 
superimposing several images on one another to measure relative tooth movements.  Bjork, 
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(1968) studied the growth rates and patterns in human patients by superimposing several 
cephalometric images, on the presence of fixed metallic implants.  It would be advantageous 
for future experiments to insert metallic implants on either side of the rat palatal midline, 
towards the posterior part of the oral cavity, to be used as fixed points, thus reliable, 
reference points to superimpose the consecutive SEM images.
This research project began with the idea of utilizing bioresorbable, sustained release, 
microspheres as a vehicle to painlessly deliver a NSAID topically to inhibit tooth movement.  
Although we were not successful in using this animal model, there were sufficient 
methodology issues that call for this idea to be studied further.  It remains possible, that by 
modifying the methods used in this study and incorporating this innovative concept of gently 
placing bioresorbable microspheres directly into the gingival sulci of larger animals and 
perhaps one day in humans, anchorage values of teeth could be enhanced.  If so, this may 
become an alternative to temporary skeletal anchorage screws and pins. 
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APPENDIX A
RAT WEIGHT CHANGES DURING THE EXPERIMENTAL STUDY
EXPANSION PHASE
Rat weight (g)
Day C1 C2 D1 D2 E1 E2 F1 F2 G1 G2 H1 H2
1 210 230 210 210 215 225 321 300 280 280 330 315
5 244 252 251 242 350 335 295 295 335 320
7 216 249
9 269 266 277 274 385 360 300 305 345 340
11 289 275
13 308 280 380 315 350 335
14 305 305 395
15 324 298
16 290 275
17 282 415 380 315 315 385 360
18 290 277
Table A1:  Weight of rats during expansion phase. 
RELAPSE PHASE
Rat weight (g)
Day C1 C2 D1 D2 E1 E2 F1 F2 G1 G2 H1 H2
1 430 370 450 415 420 405 505 460 360 365 310 280
5 420 350 450 415 420 410 520 465 370 365
6 280 250
9 420 345 450 410 425 415 515 465 380 365
10 290 280
13 425 360 465 430 440 430 525 480 390 360 345
14 330
Table A2:  Weight of rats during relapse phase.
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APPENDIX B
SUMMARY OF RAT C1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  179.10 499.53 530.66
Pt. #3  -547.97 175.93 575.52
Pt. #2  612.26 267.43 668.12
Pt. #3  -620.34 370.65 722.64
Pt. #2 901.12 106.48 907.39
Pt. #3 -710.50 278.49 763.13
Pt. #2 658.52 141.20 673.48
Pt. #3 -1035.12 164.25 1048.07
-15.90
+55.62
UR 1st molar 
(Pt. 3)
UR 1st molar 
(Pt. 3)
UR 1st molar 
(Pt. 3)
UR 1st molar 
(Pt. 3)
Rat C1 tooth movement measurements during expansion phase
Day 9
Day 13
Day 16
Day 5 +8.45
+8.16
Table B1: Rat C1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth. In rat C1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movements of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth.
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 Rat C1 movement of pts. 1, 2, 3, 4 during the expansion phase 
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Figure B1: Rat C1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure B2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat C1. The distances (µm) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX C
SUMMARY OF RAT C2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  360.40 255.34 441.68
Pt. #3  -458.23 108.19 470.83
Pt. #2  715.14 86.81 720.39
Pt. #3  -769.46 178.53 789.90
Pt. #2 895.91 -64.89 898.26
Pt. #3 -835.80 115.31 843.71
Pt. #2 588.31 274.56 649.22
Pt. #3 -1189.89 97.93 1193.91
Day 16 UL 1st molar (Pt. 2) -83.90
Day 9 UL 1st molar (Pt. 2) -8.80
Day 13 UL 1st molar (Pt. 2) +6.07
Rat C2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2) -6.19
Table C1: Rat C2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat C2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movements of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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 Rat C2 movement of pts. 1, 2, 3, 4 during the expansion phase 
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Figure C1: Rat C2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images. 
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Figure C2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat C2. The distances (µm) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX D
SUMMARY OF RAT D2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  
Pt. #3  
Pt. #2  
Pt. #3  
Pt. #2 
Pt. #3 
Pt. #2 306.72 -63.64 313.26
Pt. #3 -318.32 78.10 327.76
Day 18 UL 1st molar (Pt. 2) -4.42
Day 11 UL 1st molar (Pt. 2)
Day 15 UL 1st molar (Pt. 2)
Rat D2 tooth movement measurements during expansion phase
Day 7 UL 1st molar (Pt. 2)
Table D1: Rat D2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat D2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movement of pts. 2 and 3 was measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movement of the KT treated tooth was calculated relative to the saline treated tooth. 
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 Rat D2 movement of pts. 1, 2, 3, 4 during the expansion phase 
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Figure D1: Rat D2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure D2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat D2. The distance (µm) moved by the KT treated tooth (black bar) and 
by the saline treated tooth (white bar) is given at day 18.
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APPENDIX E
SUMMARY OF RAT E1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2 432.85 347.66 555.18
Pt. #3 -524.69 151.28 546.06
Day 16 UR 1st molar (Pt. 3)
Day 9 UR 1st molar (Pt. 3)
Day 14 UR 1st molar (Pt. 3) -1.64
Rat E1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3)
Table E1: Rat E1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat E1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 was measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movement of the KT treated tooth was calculated relative to the saline treated tooth. 
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Rat E1 movements of pts. 1, 2, 3, 4 during the expansion phase
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Figure E1: Rat E1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure E2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat E1. The distance (µm) moved by the KT treated tooth (black bar) and 
by the saline treated tooth (white bar) is given at day 14.
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APPENDIX F
SUMMARY OF RAT F1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  
Pt. #3  
Pt. #2  462.23 -62.84 466.48
Pt. #3  -116.00 302.66 324.13
Pt. #2 625.00 100.18 632.98
Pt. #3 -631.38 432.29 765.19
Pt. #2 
Pt. #3 
Day 17 UR 1st molar (Pt. 3)
Day 9 UR 1st molar (Pt. 3) -30.51
Day 14 UR 1st molar (Pt. 3) +20.89
Rat F1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3)
Table F1: Rat F1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat F1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure F1: Rat F1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure F2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat F1. The distances (µm) moved by KT treated teeth (black bars) and by 
the saline treated teeth (white bars) are given at each time point.
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APPENDIX G
SUMMARY OF RAT F2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  241.12 244.47 343.37
Pt. #3  -320.04 353.24 476.65
Pt. #2  600.57 383.26 712.44
Pt. #3  -380.60 542.98 663.08
Pt. #2 
Pt. #3 
Pt. #2 767.98 311.38 828.71
Pt. #3 -942.14 276.93 982.00
Day 18 UL 1st molar (Pt. 2) -15.61
Day 9 UL 1st molar (Pt. 2) +7.44
Day 13 UL 1st molar (Pt. 2)
Rat F2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2) -27.96
Table G1: Rat F2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat F2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure G1: Rat F2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure G2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat F2. The distances (µm) moved by KT treated teeth (black bars) and by 
the saline treated teeth (white bars) are given at each time point.
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APPENDIX H
SUMMARY OF RAT G1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  
Pt. #3  
Pt. #2  
Pt. #3  
Pt. #2 
Pt. #3 
Pt. #2 616.48 123.69 628.77
Pt. #3 -730.14 268.22 777.84
Day 17 UR 1st molar (Pt. 3) +23.71
Day 9 UR 1st molar (Pt. 3)
Day 13 UR 1st molar (Pt. 3)
Rat G1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3)
Table H1: Rat G1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth. In rat G1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 was measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in
movement of the KT treated tooth was calculated relative to the saline treated tooth.
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Figure H1: Rat G1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure H2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat G1. The distances (µm) moved by KT treated tooth (black bar) and by 
the saline treated tooth (white bar) are given at day 17.
66
APPENDIX I
SUMMARY OF RAT G2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  242.11 218.82 326.34
Pt. #3  -564.81 -28.48 565.53
Pt. #2  458.03 202.06 500.62
Pt. #3  -457.72 109.42 470.61
Pt. #2 462.80 76.73 469.11
Pt. #3 -380.29 58.21 384.72
Pt. #2 766.65 396.90 863.30
Pt. #3 -715.36 274.11 766.08
Rat G2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2) -42.29
Day 17 UL 1st molar (Pt. 2) +12.69
Day 9 UL 1st molar (Pt. 2) +6.38
Day 13 UL 1st molar (Pt. 2) +21.94
Table I1: Rat G2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat G2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure I1: Rat G2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure I2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat G2. The distances (µm) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX J
SUMMARY OF RAT H1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  
Pt. #3  
Pt. #2  176.00 260.29 314.21
Pt. #3  -390.39 126.42 410.35
Pt. #2 352.02 234.18 422.80
Pt. #3 -405.56 267.80 486.00
Pt. #2 234.20 405.99 468.70
Pt. #3 -754.13 209.92 782.80
Rat H1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3)
Day 17 UR 1st molar (Pt. 3) +67.02
Day 9 UR 1st molar (Pt. 3) +30.60
Day 13 UR 1st molar (Pt. 3) +14.9478085
Table J1: Rat H1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth. In rat H1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth.
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Figure J1: Rat H1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure J2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat H1. The distances ( m) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX K
SUMMARY OF RAT H2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  360.40 255.34 441.68
Pt. #3  -458.23 108.19 470.83
Pt. #2  715.14 86.81 720.39
Pt. #3  -769.46 178.53 789.90
Pt. #2 895.91 -64.89 898.26
Pt. #3 -835.80 115.31 843.71
Pt. #2 588.31 274.56 649.22
Pt. #3 -1189.89 97.93 1193.91
Day 16 UL 1st molar (Pt. 2) -83.90
Day 9 UL 1st molar (Pt. 2) -8.80
Day 13 UL 1st molar (Pt. 2) +6.07
Rat C2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2) -6.19
Table K1: Rat H2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat H2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure K1: Rat H2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure K2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat H2. The distances (µm) moved by KT treated teeth (black bars) and
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX L
SUMMARY OF RAT D1 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  258.54 170.47 309.68
Pt. #3  -509.19 35.00 510.39
Pt. #2  300.56 -70.99 308.83
Pt. #3  -406.87 -203.66 454.99
Pt. #2 612.51 -54.55 614.93
Pt. #3 -534.10 27.46 534.81
Day 9 UR 1st molar (Pt. 3) +47.33
Day 13 UR 1st molar (Pt. 3) -13.03
Rat D1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3) +64.81
Table K1: Rat D1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth. In rat D1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth.
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Figure K1: Rat D1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure K2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat D1. The distances (µm) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX M
SUMMARY OF RAT E2 EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  143.85 131.35 194.80
Pt. #3  -366.47 74.20 373.91
Pt. #2  284.04 217.16 357.55
Pt. #3  -499.00 169.19 526.91
Pt. #2 432.02 -59.74 436.13
Pt. #3 -351.69 -1.26 351.69
Day 9 UL 1st molar (Pt. 2) -32.14
Day 13 UL 1st molar (Pt. 2) +24.01
Rat E2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2) -47.90
Table M1: Rat E2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat E2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure M1: Rat E2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images. 
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Figure M2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat E2. The distances (µm) moved by KT treated teeth (black bars) and 
by the saline treated teeth (white bars) are given at each time point.
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APPENDIX N
SUMMARY OF RAT F1 SECOND EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  268.53 53.68 273.85
Pt. #3  -147.05 -6.75 147.20
Pt. #2  209.06 134.16 248.41
Pt. #3  -128.38 58.79 141.21
Pt. #2 422.71 248.42 490.30
Pt. #3 -111.53 113.94 159.44
Day 9 UR 1st molar (Pt. 3) -43.16
Day 13 UR 1st molar (Pt. 3) -67.48
Rat F1 tooth movement measurements during expansion phase
Day 5 UR 1st molar (Pt. 3) -46.25
Table N1: Rat F1 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth. In rat F1, KT 
was injected near the UR first molar (pt. 3), while the UL first molar (pt. 2) was the control 
side.  The total movement of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth.
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Figure N1: Rat F1 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure N2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat F1. The distances (µm) moved by KT treated teeth (black bars) and by 
the saline treated teeth (white bars) are given at each time point.
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APPENDIX O
SUMMARY OF RAT F2 SECOND EXPANSION PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  
Pt. #3  
Pt. #2  176.26 206.38 271.41
Pt. #3  -211.35 276.04 347.66
Pt. #2 128.36 66.01 144.34
Pt. #3 -262.84 -20.39 263.63
Day 9 UL 1st molar (Pt. 2) -21.93
Day 13 UL 1st molar (Pt. 2) -45.25
Rat F2 tooth movement measurements during expansion phase
Day 5 UL 1st molar (Pt. 2)
Table O1: Rat F2 tooth movement measurements during expansion phase.  Reported in the 
table are the time points when the appliances were retained in the rat’s mouth.  In rat F2, KT 
was injected near the UL first molar (pt. 2), while the UR first molar (pt. 3) was the control 
side.  The total movements of pts. 2 and 3 were measured from the midpoint of the line 
connecting pts. 1 and 4 of the SEM image taken on day 1. The percentage difference in 
movements of the KT treated teeth was calculated relative to the saline treated teeth. 
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Figure O1: Rat F2 movement of pts. 1, 2, 3, 4 during the expansion phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure O2: Time-course movements of KT and saline treated first molars during the 
expansion phase in rat F2. The distances (µm) moved by KT treated teeth (black bars) and by 
the saline treated teeth (white bars) are given at each time point.
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APPENDIX P
SUMMARY OF RAT C1 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  -10.34 210.37 210.63
Pt. #3  -196.57 82.91 213.34
Pt. #2  -32.40 59.03 67.34
Pt. #3  -273.15 -45.03 276.84
Pt. #2 30.50 -30.67 43.26
Pt. #3 -117.05 -149.66 190.00
Day 9 UR 1st molar (Pt. 3) +311.13
Day 13 UR 1st molar (Pt. 3) +339.24
Rat C1 tooth movement measurements during relapse phase
Day 5 UR 1st molar (Pt. 3) +1.29
Table P1: Rat C1 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken. In rat C1, KT was injected near the UR 
first molar (pt. 3), while the UL first molar (pt. 2) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth.
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Figure P1: Rat C1 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure P2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat C1. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX Q
SUMMARY OF RAT C2 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  74.49 107.63 130.89
Pt. #3  210.15 215.51 301.01
Pt. #2  -46.34 44.55 64.28
Pt. #3  69.83 228.42 238.86
Pt. #2 36.20 -253.61 256.18
Pt. #3 272.07 -86.85 285.60
Day 9 UL 1st molar (Pt. 2) -73.09
Day 13 UL 1st molar (Pt. 2) -10.30
Rat C2 tooth movement measurements during relapse phase
Day 5 UL 1st molar (Pt. 2) -56.52
Table Q1: Rat C2 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken.  In rat C2, KT was injected near the UL 
first molar (pt. 2), while the UR first molar (pt. 3) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth. 
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Figure Q1: Rat C2 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure Q2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat C2. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
84
APPENDIX R
SUMMARY OF RAT D2 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  2.96 9.97 10.40
Pt. #3  -57.06 159.41 169.32
Pt. #2  87.42 -118.75 147.46
Pt. #3  -9.11 155.64 155.90
Pt. #2 107.42 -275.46 295.66
Pt. #3 3.33 -121.45 121.50
Day 9 UL 1st molar (Pt. 2) -5.42
Day 13 UL 1st molar (Pt. 2) +143.34
Rat D2 tooth movement measurements during relapse phase
Day 5 UL 1st molar (Pt. 2) -93.86
Table R1: Rat D2 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken.  In rat D2, KT was injected near the UL 
first molar (pt. 2), while the UR first molar (pt. 3) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth. 
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Figure R1: Rat D2 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure R2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat D2. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX S
SUMMARY OF RAT E1 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  75.53 -118.78 140.76
Pt. #3  162.37 -49.92 169.87
Pt. #2  140.24 -173.40 223.01
Pt. #3  120.18 -163.27 202.73
Pt. #2 134.04 -153.60 203.86
Pt. #3 162.96 -145.40 218.40
Day 9 UR 1st molar (Pt. 3) -9.09
Day 13 UR 1st molar (Pt. 3) +7.13
Rat E1 tooth movement measurements during relapse phase
Day 5 UR 1st molar (Pt. 3) +20.68
Table S1: Rat E1 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken. In rat E1, KT was injected near the UR 
first molar (pt. 3), while the UL first molar (pt. 2) was the control side.  The total movement 
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth.
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Figure S1: Rat E1 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure S2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat E1. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX T
SUMMARY OF RAT G1 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  -105.97 94.02 141.67
Pt. #3  31.47 -189.37 191.96
Pt. #2  -130.10 -15.42 131.01
Pt. #3  178.65 -338.44 382.70
Pt. #2 -315.84 71.53 323.83
Pt. #3 32.62 -318.59 320.25
Day 9 UR 1st molar (Pt. 3) +192.11
Day 13 UR 1st molar (Pt. 3) -1.11
Rat G1 tooth movement measurements during relapse phase
Day 5 UR 1st molar (Pt. 3) +35.50
Table T1: Rat G1 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken. In rat G1, KT was injected near the UR 
first molar (pt. 3), while the UL first molar (pt. 2) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth.
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Figure T1: Rat G1 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure T2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat G1. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX U
SUMMARY OF RAT G2 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  12.60 39.92 41.87
Pt. #3  98.30 -60.60 115.48
Pt. #2  -240.42 50.80 245.72
Pt. #3  51.42 -107.49 119.15
Pt. #2 -98.97 143.41 174.25
Pt. #3 177.87 22.78 179.32
Day 9 UL 1st molar (Pt. 2) +106.23
Day 13 UL 1st molar (Pt. 2) -2.83
Rat G2 tooth movement measurements during relapse phase
Day 5 UL 1st molar (Pt. 2) -63.74
TableU1: Rat G2 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken.  In rat G2, KT was injected near the UL 
first molar (pt. 2), while the UR first molar (pt. 3) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth. 
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Figure U1: Rat G2 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure U2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat G2. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX V
SUMMARY OF RAT H1 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  60.16 -211.90 220.27
Pt. #3  -29.60 -227.70 229.61
Pt. #2  53.90 -375.22 379.07
Pt. #3  76.41 -371.69 379.46
Pt. #2 67.52 -97.75 118.80
Pt. #3 -33.27 -162.27 165.64
Day 10 UR 1st molar (Pt. 3) +0.10
Day 13 UR 1st molar (Pt. 3) +39.43
Rat H1 tooth movement measurements during relapse phase
Day 6 UR 1st molar (Pt. 3) +4.24
Table V1: Rat H1 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken. In rat H1, KT was injected near the UR 
first molar (pt. 3), while the UL first molar (pt. 2) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth.
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Figure V1: Rat H1 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure V2: Time-course movements of KT and saline treated first molars during the relapse 
phase in rat H1. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
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APPENDIX W
SUMMARY OF RAT H2 RELAPSE PHASE DATA
KT Injection 
site
Reference 
Points
Change in X 
Coordinate 
(um)
Change in Y 
Coordinate 
(um)
Total 
movement 
(um)
Relative 
movement of 
KT vs. saline 
treated teeth 
(%)
Pt. #2  -33.07 -187.27 190.16
Pt. #3  -13.62 -61.18 62.68
Pt. #2  -6.90 -215.74 215.85
Pt. #3  111.82 -101.29 150.88
Pt. #2 39.59 -151.80 156.87
Pt. #3 142.46 -27.33 145.05
Day 10 UL 1st molar (Pt. 2) +43.06
Day 14 UL 1st molar (Pt. 2) +8.15
Rat H2 tooth movement measurements during relapse phase
Day 6 UL 1st molar (Pt. 2) +203.39
TableW1: Rat H2 tooth movement measurements during relapse phase.  Reported in the table 
are the time points when impressions were taken.  In rat H2, KT was injected near the UL 
first molar (pt. 2), while the UR first molar (pt. 3) was the control side.  The total movements
of pts. 2 and 3 were measured from the midpoint of the line connecting pts. 1 and 4 of the 
SEM image taken on day 1. The percentage difference in movements of the KT treated teeth 
was calculated relative to the saline treated teeth. 
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Figure W1: Rat H2 movement of pts. 1, 2, 3, 4 during the relapse phase.  Pts. 2 and 3 were 
localized on the investigative teeth, UL and UR first molars, respectively.  Pts. 1 and 4 were 
localized on the UL and UR third molars, respectively, that did not undergo orthodontic 
expansion. The midpoint of the line connecting pts. 1 and 4 of the SEM image taken on day 1 
was considered the reference point and used to superimpose the consecutive series of SEM 
images.
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Figure W2 Time-course movements of KT and saline treated first molars during the relapse 
phase in rat H2. The distances (µm) moved by KT treated teeth (black bars) and by the saline 
treated teeth (white bars) are given at each time point.
96
REFERENCES
Allison AC, Chin RC, Cheng Y. Cyclooxygenase inhibitors vary widely in potency for 
preventing cytokine-induced bone resorption. Ann N Y Acad Sci. 1993 30;696:303-6.
Bjork A. The use of metallic implants in the study of facial growth in children: method and 
application. Am J Phys Anthropol. 1968 29:243-54.
Boekenoogen DI, Sinha PK, Nanda RS, Ghosh J, Currier GF, Howes RI. The effects of 
exogenous prostaglandin E2 on root resorption in rats. Am J Orthod Dentofacial 
Orthop. 1996, 109:277-86. 
Chellman GJ, Lollini LO, Dorr AE, DePass LR. Comparison of ketorolac tromethamine with 
other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and 
muscle damage in the rat. Hum Exp Toxicol. 1994 13:111-7. 
Chumbley AB, Tuncay OC. The effect of indomethacin (an aspirin-like drug) on the rate of 
orthodontic tooth movement. Am J Orthod. 1986, 89:312-4. 
Davidovitch Z, Nicolay OF, Ngan PW, Shanfeld JL. Neurotransmitters, cytokines, and the 
control of alveolar bone remodeling in orthodontics. Dent Clin North Am. 1988, 
32:411-35.
Davidovitch Z. Tooth movement. Crit Rev Oral Biol Med. 1991 2:411-50.
Dinarello CA. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector 
molecules in autoimmune diseases. Curr Opin Immunol. 1991 3:941-8.
Dolce C, Vakani A, Archer L, Morris-Wiman JA, Holliday LS. Effects of echistatin and an 
RGD peptide on orthodontic tooth movement. J Dent Res. 2003, 82:682-6.
Giunta D, Keller J, Nielsen FF, Melsen B. Influence of indomethacin on bone turnover 
related to orthodontic tooth movement in miniature pigs. Am J Orthod Dentofacial 
Orthop. 1995, 108:361-6. 
Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA. Peripheral prostanoid levels and 
nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue 
injury model. Clin Pharmacol Ther. 2002, 72:175-83. 
Grieve WG 3rd, Johnson GK, Moore RN, Reinhardt RA, DuBois LM. Prostaglandin E 
(PGE) and interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during 
human orthodontic tooth movement. Am J Orthod Dentofacial Orthop. 1994, 
105:369-74. 
97
Harris M, Jenkins MV, Bennett A, Willis MR. Prostaglandin production and bone resorption 
by dental cysts. Nature. 1973, 245:213-5.
Igarashi K, Mitani H, Adachi H, Shinoda H. Anchorage and retentive effects of a 
bisphosphonate (AHBuBP) on tooth movements in rats. Am J Orthod Dentofacial 
Orthop. 1994, 106:279-89. 
Iida J, Inage S, Kurihara S, Miura F. Changes in the microvasculature after mechanical 
pressure on the hamster cheek pouch. J Dent Res. 1992 71:1304-9.
Iida J, Warita H, Nakagawa N, Soma K. White blood cell movement in post-capillary venule 
during intermittent or continuous compressions. In: Davidovitch Z, Norton LA (Eds.) 
Biological mechanisms of tooth movement and craniofacial adaptation. Harvard 
Society for the Advancement of Orthodontics, Boston, Massachusetts, 1996 pp. 189-
194.
Irwin MG, Cheung KM, Nicholls JM, Thompson N. Intra-articular injection of ketorolac in 
the rat knee joint: effect on articular cartilage and synovium. Br J Anaesth. 1998, 
80:837-9. 
Jee WS, Li XJ, Schaffler MB. Adaptation of diaphyseal structure with aging and increased 
mechanical usage in the adult rat: a histomorphometrical and biomechanical study. 
Anat Rec. 1991 230:332-8.
Jeffcoat MK, Reddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP, Nelson SL, 
Goodale MB, Wehmeyer KR. A comparison of topical ketorolac, systemic 
flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J 
Periodontol. 1995 66:329-38. 
Kale S, Kocadereli I, Atilla P, Asan E. Comparison of the effects of 1,25 
dihydroxycholecalciferol and prostaglandin E2 on orthodontic tooth movement. Am J 
Orthod Dentofacial Orthop. 2004, 125:607-14. 
Kalia S, Melsen B, Verna C. Tissue reaction to orthodontic tooth movement in acute and 
chronic corticosteroid treatment. Orthod Craniofac Res. 2004, 7:26-34.
Kantor HS, Hampton M. Indomethacin in submicromolar concentrations inhibits cyclic 
AMP-dependent protein kinase. Nature. 1978;276:841-842 
Kehoe MJ, Cohen SM, Zarrinnia K, Cowan A. The effect of acetaminophen, ibuprofen, and 
misoprostol on prostaglandin E2 synthesis and the degree and rate of orthodontic 
tooth movement. Angle Orthod. 1996;66:339-49. 
Kelm GR, Buchanan W, Meredith MP, Offenbacher S, Mankodi SM, Dobrozsi DJ, Bapat 
NV, Collins JG, Wehmeyer KR, Eichhold TH, Doyle MJ. Evaluation of ketorolac 
98
concentrations in plasma and gingival crevicular fluid following topical treatment 
with oral rinses and dentifrices. J Pharm Sci. 1996 85:842-7.
Khouw FE, Goldhaber P. Changes in vasculature of the periodontium associated with tooth 
movement in the rhesus monkey and dog. Arch Oral Biol. 1970 15:1125-32.
Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. 
Endocrinology 1970 86:1436-40
Kobayashi Y, Takagi H, Sakai H, Hashimoto F, Mataki S, Kobayashi K, Kato Y. Effects of 
local administration of osteocalcin on experimental tooth movement. Angle Orthod. 
1998, 68:259-66. 
Kvam E. Cellular dynamics on the pressure side of the rat periodontium following 
experimental tooth movement. Scand J Dent Res. 1972 80:369-83.
Kyrkanides S, O'Banion MK, Subtelny JD. Nonsteroidal anti-inflammatory drugs in 
orthodontic tooth movement: metalloproteinase activity and collagen synthesis by 
endothelial cells. Am J Orthod Dentofacial Orthop. 2000, 118:203-9. 
Lee KJ, Park YC, Yu HS, Choi SH, Yoo YJ. Effects of continuous and interrupted 
orthodontic force on interleukin-1beta and prostaglandin E2 production in gingival 
crevicular fluid. Am J Orthod Dentofacial Orthop. 2004, 125:168-77. 
Leiker BJ, Nanda RS, Currier GF, Howes RI, Sinha PK. The effects of exogenous 
prostaglandins on orthodontic tooth movement in rats. Am J Orthod Dentofacial 
Orthop. 1995, 108:380-8. 
McCulloch CA, Melcher AH. Cell migration in the periodontal ligament of mice. J 
Periodontal Res. 1983 Jul;18(4):339-52. 
McCulloch CA, Nemeth E, Lowenberg B, Melcher AH. Paravascular cells in endosteal 
spaces of alveolar bone contribute to periodontal ligament cell populations. Anat Rec. 
1987 219:233-42. 
Mohammed AH, Tatakis DN, Dziak R. Leukotrienes in orthodontic tooth movement. Am J 
Orthod Dentofacial Orthop. 1989, 95:231-7. 
Mroszczak EJ, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, Tokes LG, Maddox 
ML, Cho DK. Ketorolac tromethamine absorption, distribution, metabolism, 
excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos. 1987 
15:618-26.
Murakami M, Kudo I. Recent advances in molecular biology and physiology of the 
prostaglandinE2-biosynthetic pathway. Prog Lipid Res. 2004, 43:3-35.
99
Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E in crevicular fluid. J 
Clin Periodontol. 1981, 8:359-67. 
Ozaki K, Hanazawa S, Takeshita A, Chen Y, Watanabe A, Nishida K, Miyata Y, Kitano S. 
Interleukin-1 beta and tumor necrosis factor-alpha stimulate synergistically the 
expression of monocyte chemoattractant protein-1 in fibroblastic cells derived from 
human periodontal ligament. Oral Microbiol Immunol. 1996 11:109-14.
Pasloske K, Burger J, Conlon P. Plasma prostaglandin E2 concentrations after single dose 
administration of ketorolac tromethamine (Toradol) in dogs. Can J Vet Res. 1998, 
62:237-40. 
Proffit WR, Fields HW. Chapter 9: Biological bases of orthodontic therapy. In: Proffit WR 
(Ed.) Contemporary orthodontics. 3rd ed., St. Louis, CV Mosby Co., 2000, pp. 296-
325.
Ren Y, Maltha JC, Kuijpers-Jagtman AM. The rat as a model for orthodontic tooth 
movement-a critical review and proposed solution. Eur J Orthod. 2004, 26:483-90.
Saito M, Saito S, Ngan PW, Shanfeld J, Davidovitch Z. Interleukin 1 beta and prostaglandin 
E are involved in the response of periodontal cells to mechanical stress in vivo and in 
vitro. Am J Orthod Dentofacial Orthop. 1991, 99:226-40. 
Sandy JR, Harris M. Prostaglandins and tooth movement. Eur J Orthod. 1984, 6:175-82.
Sari E, Olmez H, Gurton AU. Comparison of some effects of acetylsalicylic acid and 
rofecoxib during orthodontic tooth movement. Am J Orthod Dentofacial Orthop. 
2004, 125:310-5.
Scheurer PA, Firestone AR, Burgin WB. Perception of pain as result of orthodontic treatment 
with fixed appliances. Eur J Orthod. 1996, 18:349-357.
Sinha VR, Trehan A. Formulation, characterization, and evaluation of ketorolac 
tromethamine-loaded biodegradable microspheres. Drug Deliv. 2005 12:133-9.
Smith RK, Roberts WE. Cell kinetics of the initial response to orthodontically induced 
osteogenesis in rat molar periodontal ligament. Calcif Tissue Int. 1980 30:51-6.
Soma S, Iwamoto M, Higuchi Y, Kurisu K. Effects of continuous infusion of PTH on 
experimental tooth movement in rats. J Bone Miner Res. 1999, 14:546-54. 
Stephenson TJ. Inflammation. In: Underwood JCE (Ed.) General and systematic pathology. 
Churchill Livingstone, London, pp.177-200.
Storey E. The nature of tooth movement. Am J Orthod. 1973 63:292-314.
100
Vandevska-Radunovic V. Neural modulation of inflammatory reactions in dental tissues 
incident to orthodontic tooth movement. A review of the literature. Eur J Orthod. 
1999 21:231-47.
Vandevska-Radunovic V, Kristiansen AB, Heyeraas KJ, Kvinnsland S. Changes in blood 
circulation in teeth and supporting tissues incident to experimental tooth movement. 
Eur J Orthod. 1994 16:361-9.
Yamaguchi M, Kasai K. Inflammation in periodontal tissues in response to mechanical 
forces. Arch Immunol Ther Exp 2005, 53:388-398.
Yamasaki K. The role of cyclic AMP, calcium, and prostaglandins in the induction of 
osteoclastic bone resorption associated with experimental tooth movement. J Dent 
Res. 1983 62:877-81. 
Yamasaki K, Miura F, Suda T. Prostaglandin as a mediator of bone resorption induced by 
experimental tooth movement in rats. J Dent Res. 1980, 59:1635-42. 
Yamasaki K, Shibata Y, Fukuhara T. The effect of prostaglandins on experimental tooth 
movement in monkeys (Macaca fuscata). J Dent Res. 1982, 61:1444-6. 
Yamasaki K, Shibata Y, Imai S, Tani Y, Shibasaki Y, Fukuhara T. Clinical application of 
prostaglandin E1 (PGE1) upon orthodontic tooth movement. Am J Orthod. 1984, 
85:508-18. 
Wong A, Reynolds EC, West VC. The effect of acetylsalicylic acid on orthodontic tooth 
movement in the guinea pig. Am J Orthod Dentofacial Orthop. 1992, 102:360-5. 
Zhou D, Hughes B, King G. Histomorphometric and biochemical study of osteoclasts at 
orthodontic compression sites in the rat during indomethacin inhibition. Arch Oral 
Biol. 1997,42:717-26
